These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31892977)

  • 21. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
    Liu L; Wang LH; Ren YB; Rao XS; Yang SM
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
    [No Abstract]   [Full Text] [Related]  

  • 22. Functional genomics analysis reveals a MYC signature associated with a poor clinical prognosis in liposarcomas.
    Tran D; Verma K; Ward K; Diaz D; Kataria E; Torabi A; Almeida A; Malfoy B; Stratford EW; Mitchell DC; Bryan BA
    Am J Pathol; 2015 Mar; 185(3):717-28. PubMed ID: 25622542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
    Pedeutour F; Maire G; Sirvent N;
    Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Expression of Perilipin Family Proteins can be used as Diagnostic Markers of Liposarcoma and to Differentiate Subtypes.
    Zhang Q; Zhang P; Li B; Dang H; Jiang J; Meng L; Zhang H; Zhang Y; Wang X; Li Q; Wang Y; Liu C; Li F
    J Cancer; 2020; 11(14):4081-4090. PubMed ID: 32368290
    [No Abstract]   [Full Text] [Related]  

  • 25. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
    Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
    Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.
    de Vreeze RS; de Jong D; Koops W; Nederlof PM; Ariaens A; Haas RL; van Coevorden F
    Int J Cancer; 2011 Feb; 128(4):778-86. PubMed ID: 20473880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dedifferentiated Liposarcoma With Myofibroblastic Differentiation.
    Wang GY; Lucas DR
    Arch Pathol Lab Med; 2018 Oct; 142(10):1159-1163. PubMed ID: 30281365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposarcoma: new entities and evolving concepts.
    Dei Tos AP
    Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
    Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
    Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposarcoma with meningothelial-like whorls: a study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma.
    Fanburg-Smith JC; Miettinen M
    Histopathology; 1998 Nov; 33(5):414-24. PubMed ID: 9839165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytogenetics in the classification of soft tissue tumours.
    Dei Tos AP; Dal Cin P
    Virchows Arch; 1997 Aug; 431(2):83-94. PubMed ID: 9293889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.
    Iura K; Kohashi K; Hotokebuchi Y; Ishii T; Maekawa A; Yamada Y; Yamamoto H; Iwamoto Y; Oda Y
    J Pathol Clin Res; 2015 Jul; 1(3):144-59. PubMed ID: 27499900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytogenetics and molecular biology of liposarcoma].
    Xiang H; Wang J; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):165-7. PubMed ID: 12956119
    [No Abstract]   [Full Text] [Related]  

  • 35. Dedifferentiated liposarcoma of the liver.
    Kim YI; Yu ES; Lee KW; Park EU; Song HG
    Cancer; 1987 Dec; 60(11):2785-90. PubMed ID: 3677011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.
    Sandberg AA
    Cancer Genet Cytogenet; 2004 Nov; 155(1):1-24. PubMed ID: 15527898
    [No Abstract]   [Full Text] [Related]  

  • 37. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
    Beigh MM
    Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An unusual case of recurrent huge primary mediastinal dedifferentiated liposarcoma.
    Soeroso NN; Pradana A; Djaka M; Ayudika M; Ngadimin S; Soeroso L
    Int J Surg Case Rep; 2018; 50():140-143. PubMed ID: 30121443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant primary mesenteric liposarcoma: a rare case report.
    Khan N; Afroz N; Fatima U; Raza MH; Rab AZ
    Indian J Pathol Microbiol; 2007 Oct; 50(4):787-9. PubMed ID: 18306555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between expression of c-myc and p53 in liposarcoma].
    Wang YL; Qiu JS; Xiong M
    Ai Zheng; 2002 Jan; 21(1):63-7. PubMed ID: 12500400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.